Kahn, who was formerly the chief scientific and medical officer for the American Diabetic Association, said it seemed unrealistic to point consumers toward less-processed foods like fruits and vegetables because the intended audience of the Smart Choices program comprises those who might be choosing between a sugary cereal and a doughnut.

FORBES: Magazine Article

"This is a remarkably hopeful time, " says Valerie Cwik, chief medical and scientific officer at the Muscular Dystrophy Association.

WSJ: New Muscular Dystrophy Drugs Offer Hope

Allen, and led now by interim-head Nader Pourhassan and Chief Scientific Officer Dr. Richard Trauger, CytoDyn epitomizes how many new medical therapies are developed today, in virtual (read, decentralized) laboratories, by companies with short ledger sheets, and armed with two or three sharp concepts with strong therapeutic and bottom-line potential.

FORBES: Progress in Drug Therapy Marks the 25th Anniversary of World AIDS Day

Late last week, the FDA approved a new med called Eylea, which is made by Regeneron Pharmaceuticals ( see this), an upstart with board members that include such heavy hitters as former Merck ceo Roy Vagelos and, as of this morning, Marc Tessier-Lavigne, a former executive vp and chief scientific officer at Genentech, who is currently president of Rockefeller University, the medical research institution ( read here).

FORBES: The Eyes Have It: Can Regeneron Make Roche Blink?